Bank Of New York Mellon Corp Procept Bio Robotics Corp Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$38.78 - $46.78 $3.56 Million - $4.29 Million	91,693 New	91,693 $3.81 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $50.65 $605,856 - $993,094	19,607 Added 22.29%	107,574 $4.46 Million
Q2 2022 Aug 15, 2022	BUY	$29.23 - $44.45 $1.93 Million - $2.93 Million	65,888 Added 298.42%	87,967 $2.88 Million
Q1 2022 May 11, 2022	BUY	$16.89 - $35.74 $139,595 - $295,391	8,265 Added 59.83%	22,079 $772,000
Q4 2021 Feb 11, 2022	BUY	$24.6 - $46.29 $339,824 - $639,450	13,814 New	13,814 $346,000

266

38M

262K

257K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $4.17B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.